Loading…
Chemfab Alkalis (CHEMFAB)₹310.10−1.34%Commodity Chemicals
In the Sep 2026 quarter (consolidated), Chemfab Alkalis reported sales of ₹75.47 Cr, down 1.2% from Sep 2025, and net profit of −₹2.12 Cr. For the year to Mar 2026, sales were ₹310 Cr and net profit −₹3.01 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 86.18 | 82.13 | 76.34 | 81.69 | 83.39 | 92.09 | 91.29 | 76.41 | 67.93 | 74.63 | 72.97 | 75.47 |
| Expenses | 71.21 | 70.06 | 68.28 | 71.80 | 71.75 | 79.00 | 80.35 | 71.13 | 66.28 | 66.30 | 63.02 | 68.58 |
| Operating Profit | 15.16 | 12.31 | 8.31 | 10.13 | 11.89 | 13.32 | 11.27 | 5.45 | 1.92 | 8.50 | 10.11 | 7.03 |
| OPM % | 17.6% | 15.0% | 10.8% | 12.4% | 14.2% | 14.4% | 12.3% | 7.1% | 2.8% | 11.4% | 13.8% | 9.3% |
| Other Income | 1.52 | 1.91 | 2.60 | 0.61 | 2.56 | −8.54 | 1.37 | 1.77 | 2.78 | 2.81 | 2.09 | 0.38 |
| Interest | 0.44 | 0.42 | 0.95 | 1.23 | 1.21 | 1.58 | 1.58 | 1.95 | 2.04 | 2.15 | 2.22 | 2.47 |
| Depreciation | 5.44 | 5.84 | 7.29 | 8.78 | 9.60 | 10.58 | 6.38 | 6.60 | 7.45 | 7.93 | 7.76 | 7.88 |
| Profit before tax | 10.82 | 7.95 | 2.68 | 0.72 | 3.63 | −7.34 | 4.69 | −1.32 | −4.79 | 1.22 | 2.23 | −2.94 |
| Tax % | 34.4% | 32.1% | 66.7% | 172.6% | 48.1% | 25.1% | 45.8% | 51.2% | −7.0% | 60.2% | −158.1% | −28.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −8.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 7.12 | 5.43 | 0.91 | −0.54 | 1.89 | −9.23 | 2.56 | −2.02 | −4.47 | 0.49 | 5.75 | −2.12 |
| EPS (Rs) | 4.98 | 3.79 | 0.62 | −0.36 | 1.31 | −6.39 | 1.77 | −1.39 | −3.09 | 0.32 | 3.98 | −1.46 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 204 | 181 | 271 | 330 | 326 | 333 | 310 | 291 |
| Expenses | 149 | 157 | 215 | 221 | 273 | 290 | 284 | 264 |
| Operating Profit | 54.89 | 23.94 | 56.83 | 111 | 54.89 | 43.92 | 26.94 | 27.56 |
| OPM % | 27.0% | 13.0% | 21.0% | 33.0% | 17.0% | 13.0% | 9.0% | 9.5% |
| Other Income | 0.00 | 1.01 | 6.02 | 2.01 | 9.03 | −3.01 | 9.03 | 8.06 |
| Interest | 4.01 | 3.01 | 1.01 | 1.01 | 2.01 | 6.01 | 8.01 | 8.88 |
| Depreciation | 24.96 | 19.95 | 21.95 | 22.97 | 21.94 | 35.90 | 27.92 | 31.02 |
| Profit before tax | 26.97 | 2.01 | 38.97 | 88.89 | 38.98 | 0.00 | 0.00 | −4.28 |
| Tax % | 5.0% | 500.0% | 26.0% | 28.0% | 33.1% | 2,210.0% | 1,615.0% | — |
| Exceptional items | −1.99 | 0.00 | 0.00 | −1.99 | 0.99 | −2.99 | 5.99 | 0.00 |
| Net Profit | 25.08 | −8.04 | 29.09 | 65.24 | 26.09 | −7.03 | −3.01 | −0.35 |
| EPS (Rs) | 18.24 | −5.77 | 20.30 | 45.49 | 18.45 | −4.82 | −2.38 | −0.25 |
| Dividend payout % | 7.0% | 0.0% | 6.0% | 3.0% | 7.0% | −26.0% | −52.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 13.99 | 13.97 | 13.96 | 13.96 | 13.97 | 13.96 | 13.97 |
| Reserves | 263 | 254 | 285 | 348 | 374 | 367 | 362 |
| Borrowings | 43.15 | 32.12 | 9.04 | 2.01 | 20.06 | 84.30 | 126 |
| Other Liabilities | 30.15 | 36.04 | 45.94 | 47.93 | 92.96 | 57.05 | 75.63 |
| Total Liabilities | 349 | 336 | 353 | 413 | 501 | 523 | 578 |
| Fixed Assets | 195 | 202 | 194 | 192 | 247 | 317 | 387 |
| CWIP | 35.09 | 3.01 | 8.03 | 31.08 | 74.17 | 36.08 | 31.08 |
| Investments | 1.01 | 24.09 | 31.10 | 68.27 | 5.02 | 16.06 | 14.04 |
| Other Assets | 119 | 105 | 119 | 122 | 175 | 153 | 147 |
| Inventories | 7.99 | 9.01 | 11.99 | 17.01 | 16.01 | 27.02 | 26.01 |
| Trade receivables | 10.01 | 14.99 | 20.99 | 22.01 | 20.99 | 20.99 | 24.01 |
| Cash & equivalents | 3.01 | 3.01 | 8.02 | 4.01 | 25.06 | 5.01 | 1.01 |
| Total Assets | 349 | 336 | 353 | 413 | 501 | 523 | 578 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 53.83 | 44.88 | 54.87 | 92.68 | 30.91 | 39.88 | 37.91 |
| Cash from investing activity | −58.05 | −6.01 | −21.03 | −48.07 | −110 | −86.08 | −81.15 |
| Cash from financing activity | 2.99 | −15.99 | −24.98 | −8.99 | 15.99 | 58.98 | 30.97 |
| Net cash flow | −0.99 | 22.95 | 8.98 | 35.94 | −61.83 | 12.98 | −11.98 |
| Capex | 62.01 | 7.01 | 19.99 | 57.98 | 92.02 | 113 | 90.99 |
| Free cash flow | −3.99 | 37.87 | 34.91 | 39.85 | −59.82 | −70.81 | −37.89 |
| CFO / OP % | 110.1% | 157.1% | 107.1% | 97.1% | 74.1% | 104.1% | 142.1% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 18 | 32 | 30 | 25 | 25 | 24 | 29 |
| Inventory days | 83 | 78 | 53 | 88 | 59 | 99 | 91 |
| Days payable | 165 | 154 | 92 | 145 | 101 | 118 | 111 |
| Cash conversion cycle | −63 | −45 | −9 | −32 | −18 | 4 | 9 |
| Working capital days | −2 | 15 | 5 | 7 | −24 | 28 | −1 |
| ROCE % | — | 2.0% | 13.0% | 28.0% | 10.0% | 3.0% | 1.0% |
For the Sep 2026 quarter, Chemfab Alkalis reported sales of ₹75.47 Cr, down 1.2% year on year and net profit of −₹2.12 Cr. The operating margin was 9.3%.
Chemfab Alkalis' sales for the year to Mar 2026 were ₹310 Cr; over the last twelve months they were ₹291 Cr.
Net profit for the year to Mar 2026 was −₹3.01 Cr, and −₹0.35 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.25.
Chemfab Alkalis reported borrowings of ₹126 Cr at Mar 2026, against cash and equivalents of ₹1.01 Cr.
Cash from operations was ₹37.91 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹37.89 Cr.